In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 4, 2006, Pages 1552-1554

  Hoeben, Barbara J ^a,b   Burgess, David S ^a,b   McConville, Jason T ^a   Najvar, Laura K ^b   Talbert, Robert L ^a,b   Peters, Jay I ^b   Wiederhold, Nathan P ^a,b   Frei, Bradi L ^a,b   Graybill, John R ^b   Bocanegra, Rosie ^b   Overhoff, Kirk A ^a   Sinswat, Prapasri ^a   Johnston, Keith P ^a   Williams III, Robert O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; LUNG ASPERGILLOSIS; LUNG MYCOSIS; MALE; MOUSE; NEBULIZER; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

AEROSOLS; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHEMISTRY, PHARMACEUTICAL; ITRACONAZOLE; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED ICR; NANOSTRUCTURES;

EID: 33645792333     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.4.1552-1554.2006     Document Type: Article

References (23)

1. Abraham, O. C., E. K. Manavathu, J. L. Cutright, and P. H. Chandrasekar. 1999. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B. Diagn. Microbiol. Infect. Dis. 33:7-11.
2. Allen, S. D., K. N. Sorensen, M. J. Nejdl, C. Durrant, and R. T. Proffit. 1994. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. J. Antimicrob. Chemother. 34:1001-1013.
3. Chen, X., Z. Benhayoune, R. O. Williams III, and K. P. Johnston. 2005. Rapid dissolution of high potency itraconazole particles produced by evaporative precipitation into aqueous solution. J. Drug Deliv. Sci. Tech. 14:299-304.
4. Dummer, J. S., N. Lazariashvilli, J. Barnes, M. Ninan, and A. P. Milstone. 2004. A survey of anti-fungal management in lung transplantation. J. Heart Lung Transplant 23:1376-1381.
5. Edwards, D. A., A. Ben-Jebria, and R. Langer. 1998. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 85:379-385.
6. Gavalda, J., M. T. Martin, P. Lopez, X. Gomis, J. L. Ramirez, D. Rodriguez, O. Len, Y. Puigfel, I. Ruiz, and A. Pahissa. 2005. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis. Antimicrob. Agents Chemother. 49:3028-3030.
7. Gubbins, P. O., B. J. Gurley, and J. Bowman. 1998. Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum. J. Pharm. Biomed. Anal. 16:1005-1012.
8. Hu, J., K. P. Johnston, and R. O. Williams III. 2004. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev. Ind. Pharm. 30:233-245.
9. Lewis, R. E., N. P. Wiederhold, and M. E. Klepser. 2005. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob. Agents Chemother. 49:945-951.
10. Marr, K. A., F. Crippa, W. Leisenring, M. Hoyle, M. Boeckh, S. A. Balajee, W. G. Nichols, B. Musher, and L. Corey. 2004. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 103:1527-1533.
11. Marr, K, A., W. Leisenring, F. Crippa, J. T. Slattery, L. Corey, M. Boeckh, and G. B. McDonald. 2004. Cyclophosphamide metabolism is affected by azole antifungals. Blood 103:1557-1559.
12. McConville, J. T., R. O. Williams III, T. C. Carvalho, A. N. Iberg, K. P. Johnston, R. L. Talbert, D. Burgess, and J. I. Peters. 2005. Design and evaluation of a restraint-free small animal inhalation dosing chamber. Drug Dev. Ind. Pharm. 31:35-42.
13. Najvar, L. K., A. Cacciapuoti, S. Hernandez, J. Halpern, R. Bocanegra, M. Gurnani, F. Menzel, D. Loebenberg, and J. R. Graybill. 2004. Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories. Antimicrob. Agents Chemother. 48:758-764.
14. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard [NCCLS document M38A]. NCCLS, Wayne, Pa.
15. Paterson, P. J., S. Seaton, H. G. Prentice, and C. C. Kibbler. 2003. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. J. Antimicrob. Chemother. 52:873-876.
16. Piggott, W. R., and C. W. Emmons. 1960. Device for inhalation exposure of animals to spores. Proc. Soc. Exp. Biol. Med. 103:805-806.
17. Rogers, T. L., J. Hu, Z. Yu, K. P. Johnston, and R. O. Williams III. 2002. A novel particle engineering technology: spray-freezing into liquid. Int. J. Pharm. 242:93-100.
18. Rogers, T. L., A. C. Nelsen, J. Hu, J. N. Brown, M. Sarkari, T. J. Young, K. P. Johnston, and R. O. Williams III. 2002. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur. J. Pharm. Biopharm. 54:271-280.
19. Ruggrok, E. J., A. G. Vulto, and E. W. Van Etten. 2001. Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats. J. Antimicrob. Chemother. 48:89-95.
20. Sarkari, M., J. Brown, X. Chen, S. Swinnea, R. O. Williams III, and K. P. Johnston. 2002. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 243:17-31.
21. Sinswat, P., X. Gao, M. J. Yacaman, R. O. Williams III, and K. P. Johnston. 2005. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution. Int. J. Pharm. 302:113-124.
22. Steinbach, W. J., D. K. Benjamin, Jr., D. P. Kontoyiannis, J. R. Perfect, I. Lutsar, K. A. Marr, M. S. Lionakis, H. A. Torres, H. Jafri, and T. J. Walsh. 2004. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin. Infect. Dis. 39:192-198.
23. Winston, D. J., R. T. Maziarz, P. H. Chandrasekar, H. M. Lazarus, M. Goldman, J. L. Blumer, G. J. Leitz, and M. C. Territo. 2003. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann. Intern. Med. 138:705-713.